Article
A weighted exact test for mutually exclusive mutations in cancer.
Bioinformatics (Oxford, England) - 1 Sept 2016
Leiserson Mark D M, Reyna Matthew A, Raphael Benjamin J
Abstract excerpt
MOTIVATION: The somatic mutations in the pathways that drive cancer development tend to be mutually exclusive across tumors, providing a signal for distinguishing driver mutations from a larger number of random passenger mutations. This mutual exclusivity signal can be confounded by high and highly variable mutation rates across a cohort of samples. Current statistical tests for exclusivity that incorporate both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
